[Intravitreal application of triamcinolone--our experiences].
To show the results of intravitreal application of triamcinolone used as a primary or adjuvant therapy. We analyzed 48 patients with different ocular disorders: exudative age related macular degeneration, diabetic retinopathy, or central retinal vein occlusion. We analyzed color fundus photography, visual acuity, fluorescein angiography and complications of intravitreal triamcinolone application. There was a marked reduction of macular edema in 70% of patients verified on fluorescein angiography. Visual acuity improved in 62% of patients. The most common complication was transient rise in intraocular pressure. There was no case of endophthalmitis. Intravitreal application of triamcinolone is relatively safe and efficacious in selected patiens with different ocular disorders.